JP2010534629A5 - - Google Patents

Download PDF

Info

Publication number
JP2010534629A5
JP2010534629A5 JP2010517329A JP2010517329A JP2010534629A5 JP 2010534629 A5 JP2010534629 A5 JP 2010534629A5 JP 2010517329 A JP2010517329 A JP 2010517329A JP 2010517329 A JP2010517329 A JP 2010517329A JP 2010534629 A5 JP2010534629 A5 JP 2010534629A5
Authority
JP
Japan
Prior art keywords
alkali metal
metal salt
hypochlorous acid
preparation according
carrier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010517329A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010534629A (ja
JP5872159B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2008/006193 external-priority patent/WO2009013019A2/en
Publication of JP2010534629A publication Critical patent/JP2010534629A/ja
Publication of JP2010534629A5 publication Critical patent/JP2010534629A5/ja
Application granted granted Critical
Publication of JP5872159B2 publication Critical patent/JP5872159B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010517329A 2007-07-26 2008-07-28 電気化学的に活性化された次亜塩素酸塩の溶液を含む医薬製剤 Expired - Fee Related JP5872159B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US95203507P 2007-07-26 2007-07-26
US60/952,035 2007-07-26
US98818107P 2007-11-15 2007-11-15
US60/988,181 2007-11-15
PCT/EP2008/006193 WO2009013019A2 (en) 2007-07-26 2008-07-28 Pharmaceutical preparations comprising electrochemically activated hypochlorite solutions

Publications (3)

Publication Number Publication Date
JP2010534629A JP2010534629A (ja) 2010-11-11
JP2010534629A5 true JP2010534629A5 (enExample) 2015-11-19
JP5872159B2 JP5872159B2 (ja) 2016-03-01

Family

ID=40239573

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010517329A Expired - Fee Related JP5872159B2 (ja) 2007-07-26 2008-07-28 電気化学的に活性化された次亜塩素酸塩の溶液を含む医薬製剤

Country Status (10)

Country Link
US (1) US20100266710A1 (enExample)
EP (1) EP2178501B1 (enExample)
JP (1) JP5872159B2 (enExample)
KR (2) KR101733723B1 (enExample)
CN (2) CN101778621B (enExample)
AU (1) AU2008280437B2 (enExample)
CA (1) CA2694929C (enExample)
ES (1) ES2671372T3 (enExample)
RU (1) RU2554802C2 (enExample)
WO (1) WO2009013019A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2374762T1 (sl) 2010-03-31 2013-05-31 Caliopa Ag Postroj in postopek za tvorjenje elektrokemično aktivirane raztopine
AP2012006545A0 (en) * 2010-03-31 2012-10-31 Caliopa Ag Electrochemically activated waterbased solution and use of the solution
EP2422792A1 (de) 2010-08-26 2012-02-29 Caliopa AG Elektrochemisch aktivierte Lösung auf Wasserbasis und Verwendung der Lösung
EP2431056A1 (de) 2010-09-16 2012-03-21 Caliopa AG Pharmazeutische Zusammensetzung, enthaltend elektrochemisch aktivierte Salzlösung
EP2543359A1 (de) * 2011-07-08 2013-01-09 Caliopa AG Gel zur Verwendung in einem Wundbehandlungsmittel
EP2567689A1 (en) * 2011-09-12 2013-03-13 Visiotact Pharma Ophthtalmic compositions comprising prostaglandin F2 alpha derivatives and hyaluronic acid
HK1203068A1 (en) * 2011-09-16 2015-10-16 Zurex Pharmagra, Llc Systems and methods for generating germicidal compositions
US10617716B2 (en) * 2014-12-16 2020-04-14 Urgo Us, Inc. Hypochlorous acid formulations and methods for treating skin conditions
WO2018074421A1 (ja) * 2016-10-21 2018-04-26 ライオン株式会社 眼科用剤及び眼科用薬
EP3716764A1 (de) 2017-11-27 2020-10-07 Sanixtreme Gmbh & Co Kg Formulierung zur bildung eines desinfizierenden schaums
EP3593862A1 (en) 2018-07-12 2020-01-15 Azad Pharma AG Electrochemically activated salt solution
EP3919047A1 (en) * 2020-06-03 2021-12-08 AZAD Pharma AG Microemulsion for the treatment of dry eye syndrome
WO2022081297A1 (en) * 2020-10-12 2022-04-21 The Regents Of The University Of Colorado, A Body Corporate Compositions and methods for lowering intracranial pressure by intranasal agent administration
US20250302868A1 (en) * 2024-03-26 2025-10-02 Ocusoft, Inc. Hypochlorous acid-based dry eye formulations

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5693337A (en) * 1994-07-13 1997-12-02 Wakamoto Pharmaceutical Co., Ltd. Stable lipid emulsion
JPH10236961A (ja) * 1997-02-25 1998-09-08 Nobel Igaku Kenkyusho:Kk 電解酸性水を用いた眼科用剤
HK1041600A1 (zh) * 1998-10-23 2002-07-12 水基Ip股份有限公司 应用杀菌溶液的方法
WO2000033757A1 (en) * 1998-12-09 2000-06-15 Advanced H¿2?O Inc. A system for decontamination of dental unit waterlines using electrolyzed water
RU2148027C1 (ru) * 1999-02-01 2000-04-27 Бахир Витольд Михайлович Способ получения дезинфицирующего раствора - нейтрального анолита анд
US7393522B2 (en) * 2000-01-12 2008-07-01 Novabay Pharmaceuticals, Inc. Physiologically balanced, ionized, acidic solution and methodology for use in wound healing
US6878287B1 (en) * 2000-02-04 2005-04-12 Radical Waters Ip (Pty) Limited Dental equipment and method of operating such equipment
RU2180605C1 (ru) * 2000-07-24 2002-03-20 Завод "Автоматика" Способ внутриушной ультразвуковой терапии хронических средних отитов
DE60326226D1 (de) * 2002-03-21 2009-04-02 Cayman Chemical Co Prostaglandin f2 alpha analoga in kombination mit einem antimikrobiellen mittel zur behandlung von glaukom
US20040191332A1 (en) 2003-03-27 2004-09-30 Allergan, Inc. Preserved ophthalmic compositions
US20050139808A1 (en) * 2003-12-30 2005-06-30 Oculus Innovative Sciences, Inc. Oxidative reductive potential water solution and process for producing same
US20050196462A1 (en) * 2003-12-30 2005-09-08 Oculus Innovative Sciences, Inc. Topical formulation containing oxidative reductive potential water solution and method for using same
KR101319772B1 (ko) * 2004-11-09 2013-10-23 노바갈리 파르마 에스 에이 면역 억제제를 포함하는 안과용 유제
CA2602411C (en) * 2005-03-23 2015-02-24 Oculus Innovative Sciences, Inc. Method of treating second and third degree burns using oxidative reductive potential water solution
CA2630816C (en) * 2005-11-28 2014-08-12 Senju Pharmaceutical Co., Ltd. Pharmaceutical comprising ppar agonist
EP1993572A2 (en) * 2006-01-20 2008-11-26 Oculus Innovative Sciences, Inc. Methods of treating or preventing sinusitis with oxidative reductive potential water solution

Similar Documents

Publication Publication Date Title
JP5872159B2 (ja) 電気化学的に活性化された次亜塩素酸塩の溶液を含む医薬製剤
JP2009523832A5 (enExample)
JP2009523830A5 (enExample)
JP2009523829A5 (enExample)
US20160143944A1 (en) Antimicrobial compositions comprising hypochlorous acid and silver
TW201605490A (zh) 組合物及其用途
JP2013535472A5 (enExample)
JP2004537571A5 (ja) 次亜塩素酸ナトリウム系消毒剤溶液、及びそれを調製する方法
AU2018263059A1 (en) Compositions and treatment procedures for the treatment of pathogenic infections
AU2019280025A1 (en) Wound treatment composition
JP2014504628A5 (enExample)
TW200427661A (en) Aqueous solution of olanexidine, method of preparing the aqueous solution, and disinfectant
PT1417970E (pt) Composto ocular anti-alérgico, anti-bacteriano e antivermelhidão
Shu et al. The treatment effect of the atopic dermatitis by electrolyticreduction ion water lotion.
JP2023180710A (ja) 視覚改善剤
BR102022001718A2 (pt) Cariostático à base de nanopartículas de prata
JP2021167307A (ja) 鼻腔または上咽頭洗浄用のうがい液
CN111602667A (zh) 一种多用途生物安全消毒剂
NZ719455B2 (en) Wound treatment composition
JP2015101584A (ja) 生薬鼻炎スプレー洗浄液
WO2011116034A1 (en) Human medicinal treatment and product typically based on salt of peroxymonosulfuric acid, and associated product fabrication